Abstract:Tyrosine phosphorylation of metabolic enzymes is an evolutionarily conserved post-translational modification that facilitates rapid and reversible modulation of enzyme activity, localization or function. Despite the high abundance of tyrosine phosphorylation events detected on metabolic enzymes in high-throughput mass spectrometry-based studies, functional characterization of tyrosine phosphorylation sites has been limited to a subset of enzymes. Since tyrosine phosphorylation is dysregulated across human diseases, including cancer, understanding the consequences of metabolic enzyme tyrosine phosphorylation events is critical for informing disease biology and therapeutic interventions. To globally identify metabolic enzyme tyrosine phosphorylation events and simultaneously assign functional significance to these sites, we performed parallel phosphoproteomics and polar metabolomics in non-tumorigenic mammary epithelial cells (MCF10A) stimulated with epidermal growth factor (EGF) in the absence or presence of the epidermal growth factor receptor (EGFR) inhibitor erlotinib. We performed an integrated analysis of the phosphoproteomic and metabolomic datasets to identify tyrosine phosphorylation sites on metabolic enzymes with functional consequences. We identified two previously characterized (PKM, PGAM1) and two novel (GSTP1, GLUD1) tyrosine phosphorylation sites on metabolic enzymes with purported functions based on metabolomic analyses. We validated these hits using a doxycycline-inducible CRISPR interference (CRISPRi) system in MCF10A cells, in which target metabolic enzymes were depleted with simultaneous re-expression of wild-type, phosphomutant or phosphomimetic isoforms. Together, these data provide a framework for identification, prioritization and characterization of tyrosine phosphorylation sites on metabolic enzymes with functional significance.

Personalized phosphoproteomics identifies functional signaling

PROTEOMICS – Clinical Applications Table of Contents

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Phosphoproteomic analysis reveals interconnected system-wide responses to perturbations of kinases and phosphatases in yeast

Targeted proteomics analyses of phosphorylation-dependent signalling networks

Site-specific metabolic labeling reveals proteome-wide phospho-dynamics

Structural and systems characterization of phosphorylation on metabolic enzymes identifies sex-specific metabolic reprogramming in obesity

The genetic and dietary landscape of the muscle insulin signalling network

Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells

µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics

Personalized phosphoproteomics of skeletal muscle insulin resistance and exercise links MINDY1 to insulin action

Spatial-proteomics reveals phospho-signaling dynamics at subcellular resolution

Spatial-proteomics reveal in-vivo phospho-signaling dynamics at subcellular resolution

Parallel phosphoproteomics and metabolomics map the global metabolic tyrosine phosphoproteome

Combining Phosphoproteomics Datasets and Literature Information to Reveal the Functional Connections in a Cell Phosphorylation Network

Phosphomatics: interactive interrogation of substrate–kinase networks in global phosphoproteomics datasets

A Quantitative Chemical Proteomic Strategy for Profiling Phosphoprotein Phosphatases from Yeast to Humans

Post-translational modification-centric base editor screens to assess phosphorylation site functionality in high throughput

Quantitative phosphoproteomics by mass spectrometry: past, present, and future

Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways

Quantitative Label-Free Phosphoproteomics Strategy for Multifaceted Experimental Designs